The Rubicon Research IPO allotment status is one of the most eagerly awaited updates for investors this week. With strong demand across all investor categories and a solid Grey Market Premium (GMP) trend, many are eager to know their allotment results.
Investors can now check their Rubicon Research IPO allotment status online through the registrar MUFG Intime India Private Limited, as well as via the NSE and BSE websites.
Rubicon Research IPO Important Dates
Event | Date |
---|---|
IPO Open Date | October 9, 2025 |
IPO Close Date | October 13, 2025 |
Basis of Allotment | October 14, 2025 |
Refunds Initiation | October 15, 2025 |
Credit to Demat Accounts | October 15, 2025 |
IPO Listing Date | October 16, 2025 |
Registrar | Link Intime India Pvt Ltd |
How to Check Rubicon Research IPO Allotment Status
Investors can check their allotment in three simple ways — via MUFG Intime, BSE, or NSE portals.
1. Check Allotment via MUFG Intime India Private Limited (Official Registrar)
Website: MUFG
Steps to check:
- Visit the official Link Intime IPO allotment page.
- Select ‘Rubicon Research Limited – IPO’ from the drop-down list.
- Enter your PAN, Application Number, or DP/Client ID.
- Click on ‘Search’ to view your allotment status.
- Your Rubicon Research IPO allotment result will appear on the screen.
2. Check Allotment on BSE Website
Website: BSE
Steps:
- Go to the BSE allotment page.
- Select Equity as the issue type.
- Choose Rubicon Research Limited from the dropdown.
- Enter your application number and PAN.
- Click on ‘I am not a robot’, then on ‘Search’.
3. Check Allotment on NSE Website
Website: NSE
Steps:
- Visit the NSE IPO allotment page.
- Log in with your registered email ID and PAN.
- Select Rubicon Research Limited IPO.
- Check your allotment status instantly.
Rubicon Research IPO GMP & Listing Expectations
As of 12 October 2025, the Rubicon Research IPO GMP stood at ₹108, indicating a listing price of around ₹593, about 22% above the upper issue price of ₹485 per share.
This suggests a strong listing gain potential, backed by positive market sentiment and robust fundamentals.
About Rubicon Research Limited
Rubicon Research Limited is a pharmaceutical development and manufacturing company focused on complex generics and drug delivery systems. The company has filed over 100 patents worldwide and operates modern R&D and manufacturing facilities in Thane and Ambernath, Maharashtra.
Rubicon Research IPO Overview
Particulars | Details |
---|---|
IPO Price Band | ₹461 – ₹485 per share |
Face Value | ₹1 per share |
Issue Size | ₹1,377.50 crore |
Fresh Issue | ₹500 crore |
Offer for Sale (OFS) | ₹877.50 crore |
Lot Size | 30 Shares |
Listing At | NSE, BSE |
Expert View
Analysts expect the Rubicon Research IPO to perform well on its listing, citing its strong R&D capabilities, patent portfolio, and global presence. However, experts advise investors to monitor valuation levels and market sentiment closely before making post-listing decisions.
Conclusion
The Rubicon Research IPO allotment status can now be checked online via Link Intime, BSE, and NSE portals.
With a positive GMP trend, solid fundamentals, and healthy investor demand, the IPO is likely to deliver moderate-to-strong listing gains if overall market momentum continues.